NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Epigenica

Epigenica

Private
SolnaHealthcare & Life Scienceshttps://www.epigenica.se/

Last Round

Grant

Sep 8, 2025

Total Funding Raised

$2.73M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Epigenica is a biotechnology company that provides a high-throughput epigenetic screening platform for biomedical research, drug discovery, and diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

epigenetic analysisepigenomic profilingbiotechnology kitsbioinformatics pipelinegenomic medicinewet-lab toolsepigeneticsclinical researchsequencing workflowpersonalized medicinelab consumablesbiotechCROclinical research organizationlife science tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epigenica Comparables

Compare Epigenica with similar companies based on industry and business-model similarity.

Epigenica comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PredictMe AB
78%
EpiCypher
76%
Arima Genomics
66%

Epigenica Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 8, 2025
SeedJun 30, 2025
SeedOct 16, 2023

Key People

Founding team and executive leadership

Banushree Kumar

Chief Technology Officer

Executive Team

Epigenica Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 18, 2026

    Partnered with PrimeTech to expand presence in Japan.

  • Jan 1, 2026

    Plans to release kit products and a service arm in 2026.

Epigenica Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Epigenica Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Epigenica's valuation, stock price, and market status.

Firmographic Details

HeadquartersSolna
Employee Range20
Year Founded2020
Last FundingSep 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.